These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1586738)

  • 1. Activation of factor X and its regulation by tissue factor pathway inhibitor in small-diameter capillaries lined with human endothelial cells.
    Lindhout T; Blezer R; Schoen P; Nordfang O; Reutelingsperger C; Hemker HC
    Blood; 1992 Jun; 79(11):2909-16. PubMed ID: 1586738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa.
    Wesselschmidt R; Likert K; Girard T; Wun TC; Broze GJ
    Blood; 1992 Apr; 79(8):2004-10. PubMed ID: 1562726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional expression of tissue factor by fibroblasts and endothelial cells under flow conditions.
    Grabowski EF; Zuckerman DB; Nemerson Y
    Blood; 1993 Jun; 81(12):3265-70. PubMed ID: 8507863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor.
    van 't Veer C; Hackeng TM; Delahaye C; Sixma JJ; Bouma BN
    Blood; 1994 Aug; 84(4):1132-42. PubMed ID: 8049429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of a continuous flow reactor to study the lipoprotein-associated coagulation inhibitor (LACI) that inhibits tissue factor.
    Gemmell CH; Broze GJ; Turitto VT; Nemerson Y
    Blood; 1990 Dec; 76(11):2266-71. PubMed ID: 2257300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surface.
    Ghosh S; Ezban M; Persson E; Pendurthi U; Hedner U; Rao LV
    J Thromb Haemost; 2007 Feb; 5(2):336-46. PubMed ID: 17092304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
    Pedersen AH; Nordfang O; Norris F; Wiberg FC; Christensen PM; Moeller KB; Meidahl-Pedersen J; Beck TC; Norris K; Hedner U
    J Biol Chem; 1990 Oct; 265(28):16786-93. PubMed ID: 2211593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of leukocyte elastase on tissue factor pathway inhibitor.
    Higuchi DA; Wun TC; Likert KM; Broze GJ
    Blood; 1992 Apr; 79(7):1712-9. PubMed ID: 1558967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.
    Rao LV; Ruf W
    Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue factor pathway inhibitor prevents thrombus formation on procoagulant subendothelial matrix.
    Lindahl AK; Sandset PM; Thune-Wiiger M; Nordfang O; Sakariassen KS
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):755-60. PubMed ID: 7865681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that plasma lipoproteins inhibit the factor VIIa-tissue factor complex by a different mechanism that extrinsic pathway inhibitor.
    Kondo S; Kisiel W
    Blood; 1987 Dec; 70(6):1947-54. PubMed ID: 3315045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of factor X activation at extracellular matrix of fibroblasts during flow conditions: a comparison between tissue factor pathway inhibitor and inactive factor VIIa.
    Valentin S; Reutlingsperger CP; Nordfang O; Lindhout T
    Thromb Haemost; 1995 Dec; 74(6):1478-85. PubMed ID: 8772224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of factor VIIa-tissue factor coagulation activity by a hybrid protein.
    Girard TJ; MacPhail LA; Likert KM; Novotny WF; Miletich JP; Broze GJ
    Science; 1990 Jun; 248(4961):1421-4. PubMed ID: 1972598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway.
    Sevinsky JR; Rao LV; Ruf W
    J Cell Biol; 1996 Apr; 133(2):293-304. PubMed ID: 8609163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa.
    Callander NS; Rao LV; Nordfang O; Sandset PM; Warn-Cramer B; Rapaport SI
    J Biol Chem; 1992 Jan; 267(2):876-82. PubMed ID: 1730676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shear stress decreases endothelial cell tissue factor activity by augmenting secretion of tissue factor pathway inhibitor.
    Grabowski EF; Reininger AJ; Petteruti PG; Tsukurov O; Orkin RW
    Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):157-62. PubMed ID: 11145948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the factor Xa-dependent inhibitor of factor VIIa/tissue factor (extrinsic pathway inhibitor) from cell supernates of cultured human umbilical vein endothelial cells.
    Warn-Cramer BJ; Almus FE; Rapaport SI
    Thromb Haemost; 1989 Feb; 61(1):101-5. PubMed ID: 2665164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of the inhibition of tissue factor-factor VIIa by tissue factor pathway inhibitor.
    Lindhout T; Franssen J; Willems G
    Thromb Haemost; 1995 Sep; 74(3):910-5. PubMed ID: 8571320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of lipoproteins on the tissue factor-dependent activation of factor X.
    Trimarchi A; Minestrini D; Palazzesi G; Cassetti M
    Int J Clin Lab Res; 1992; 22(2):115-8. PubMed ID: 1504304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces.
    Hamamoto T; Yamamoto M; Nordfang O; Petersen JG; Foster DC; Kisiel W
    J Biol Chem; 1993 Apr; 268(12):8704-10. PubMed ID: 8473315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.